Fundação Doutor Amaral Carvalho.

Jaú, São Paulo 17210120

0 studies enrolling now · 4 studies all time

What they study most

Carcinoma, Non-Small-Cell Lung, Chronic Lymphocytic Leukemia, First Line Non-Small Cell Lung Cancer, Progressive Brain Metastasis, Small Lymphocytic Lymphoma, Unresectable or Metastatic Melanoma

Studies at this site

• A Study of SGN-B6A Versus Docetaxel in Previously Treated Non-small Cell Lung Cancer — Running, not enrolling
• A Study of Pirtobrutinib (LOXO-305) Versus Bendamustine Plus Rituximab (BR) in Untreated Patients With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) — Running, not enrolling
• Study Comparing Investigational Drug HBI-8000 + Nivolumab vs. Placebo + Nivolumab in Patients With Advanced Melanoma — Running, not enrolling
• Avelumab in First-line NSCLC (JAVELIN Lung 100) — Completed